Volume 28, Issue 3

Search all International Journal of Clinical Oncology articles

March 2023

Including Invited Reviews on Association of microbiome with cancer treatment

Filter by

Volume:

Sort by

Date published:

New to old Old to new

18 articles in this issue

Association of microbiota with cancer treatment
Kiyoshi Yoshimura
Invited Review Article 27 February 2023 Pages: 341 - 346
Association of the gut microbiome with cancer immunotherapy
Motoo Nomura
Invited Review Article 14 May 2022 Pages: 347 - 353
Insight into autophagy in platinum resistance of cancer
Fang Yang
Ke Xu
Tao Ren
Review Article 27 January 2023 Pages: 354 - 362
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
Teresita Caruso
Francesca Salani
Paola Migliorini
Original Article Open access 23 January 2023 Pages: 363 - 369
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
Teresita Caruso
Francesca Salani
Paola Migliorini
Correction Open access 20 February 2023 Pages: 370 - 370
Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis
Pauline Corbaux
Catherine Terret
Pierre-Etienne Heudel
Original Article 16 January 2023 Pages: 371 - 381
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system
Shota Miyoshi
Ikuno Nishibuchi
Yasushi Nagata
Original Article 16 January 2023 Pages: 382 - 391
Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer
Ryuhei Aoyama
Koya Hida
Kazutaka Obama
Original Article 09 January 2023 Pages: 392 - 399
The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy
Taichi Horino
Ryuma Tokunaga
Hideo Baba
Original Article 13 January 2023 Pages: 400 - 408
Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention
Akifumi Nakamura
Masaki Hashimoto
Seiki Hasegawa
Original Article 07 January 2023 Pages: 409 - 415
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma
Noboru Nakaigawa
Yoshihiko Tomita
Akiko Kimura
Original Article Open access 03 January 2023 Pages: 416 - 426
The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer
Toshiki Oka
Koji Hatano
Norio Nonomura
Original Article 29 December 2022 Pages: 427 - 435
JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer
Toru Nakanishi
Toshiaki Saito
Kazuhiro Takehara
Original Article 02 February 2023 Pages: 436 - 444
Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database
Yoshihide Inayama
Kayoko Mizuno
Koji Kawakami
Original Article 04 January 2023 Pages: 445 - 453
Association between financial toxicity and health-related quality of life of patients with gynecologic cancer
Yusuke Kajimoto
Kazunori Honda
Ataru Igarashi
Original Article 17 January 2023 Pages: 454 - 467
Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma
Yasuo Takashima
Momoko Hamano
Ryuya Yamanaka
Original Article 06 January 2023 Pages: 468 - 481
Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging
Yu Nakashima
Yukihiro Yokoyama
Tomoki Ebata
Original Article 30 December 2022 Pages: 482 - 490
Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients
Takeaki Kusada
Takafumi Toita
Sadayuki Murayama
Correction Open access 16 February 2023 Pages: 491 - 491

Volume 28, Issue 3

Association of microbiota with cancer treatment

Association of the gut microbiome with cancer immunotherapy

Insight into autophagy in platinum resistance of cancer

Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies

Association of chemotherapy and comorbidities with overall survival in elderly patients with early breast cancer: a French population-based propensity score-matched analysis

Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system

Long-term results of a phase 2 study of neoadjuvant chemotherapy with molecularly targeted agents for locally advanced rectal cancer

The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy

Efficacy and safety of nivolumab with ipilimumab for recurrent malignant pleural mesothelioma after primary surgical intervention

Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer

JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer

Real-world practice of estrogen therapy after surgery for endometrial cancer: a descriptive study using a Japanese claims database

Association between financial toxicity and health-related quality of life of patients with gynecologic cancer

Reciprocal expression of the immune response genes CXCR3 and IFI44L as module hubs are associated with patient survivals in primary central nervous system lymphoma

Which modality is better to diagnose high-grade transformation in retroperitoneal liposarcoma? Comparison of computed tomography, positron emission tomography, and magnetic resonance imaging

Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncologic outcomes in Japanese patients

Navigation